Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: Activation of hepatic stellate cells as an early event

Hepatology

Volumn 26, Issue 1, 1997, Pages 128-134

  Sempoux, Christine ^a   Horsmans, Yves ^a   Geubel, André ^a   Fraikin, Joëlle ^a   Van Beers, Bernard E ^a   Gigot, Jean François ^a   Lerut, Jan ^a   Rahier, Jacques ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN FILAMENT; ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; LIVER DISEASE; LIVER SINUSOID; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIATION INJURY; VEIN OCCLUSION;

EID: 0030955881     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260117     Document Type: Article

References (35)

1. Ogata K, Hizawa K, Yoshida M, Kitamuro T, Akagi G, Kagawa K, Fukuda F. Hepatic injury following irradiation - a morphologic study - Tukushima. J Exp Med 1963;9:240-251.
2. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol 1965;93:200-208.
3. Reed GB, Cox AJ. The human liver after radiation injury. Am J Pathol 1966;48:597-612.
4. Lewin K, Millis RR. Human radiation hepatitis. A morphologic study with emphasis on the late change. Arch Pathol 1973;96:21-26.
5. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 1980;104:584-588.
6. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987;127: 549-558.
7. Robertson JM, Lawrence TS, Dworzanin LM, Andrews JC, Andrews S, Kesler ML, DuRoss DJ, et al. The treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286-1293.
8. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int Radiation Oncology Biol Phys 1995;31:1237-1248.
9. Yamasaki SA, Marn CS, Francis IR, Robertson JM, Lawrence TS. High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. Am J Roentgenol 1995;165:79-84.
10. Tsujino K, Landry JC, Smith RG, Keller JW, Williams WH, Davis LW. Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology 1995;196:275-280.
11. Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg 1991;161:454-458.
12. Schoenthaler R, Phillips TL, Castro J, Efird JT, Better A, Way LW. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg 1994;219:267-274.
13. Hsu SM, Raine L, Fouger H. The use of avidin antibody and avidin-biotin-peroxydase complex in immunoperoxydase techniques. Am J Clin Pathol 1981;75:816-821.
14. Okanoue T, Burbige EJ, French SW. The role of the Ito cells in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 1983;107:459-463.
15. Clement B, Grimaud JA, Campion JP, Deugniez Y, Guillouzo A. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. HEPATOLOGY 1986;6:225-234.
16. Yokoi Y, Namihisa T, Matsuzaki K, Miyazaki A, Yamaguchi Y. Distribution of Ito cells in experimental hepatic fibrosis. Liver 1988;8:48-52.
17. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Marumo F. Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol 1991;164:273-278.
18. Casu A, Canepa M, Nanni G. Le cellule stellate perisinusoidali o cellule di Ito ed il loro ruolo nella fibrosi epatica. Pathologica 1991;86:467-499.
19. Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F. Appearance of α-smooth-muscle actin positive cells in hepatic fibrosis. Liver 1991;11: 100-105.
20. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H. Modulation of α- smooth-muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. AmJ Pathol 1991;138:1233-1242.
21. Yamaoka K, Nouchi T, Marumo F, Sato C. α-Smooth-muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 1993;38: 1473-1479.
22. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, Hara H. Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch 1994; 424:249-256.
23. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. HEPATOLOGY 1991;13:364-375.
24. Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-1a, tumor necrosis factor α, and transforming growth factor-β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1988;9:71-78.
25. Anscher MS, Crocker IR, Jirtle RL. Transforming growth factor-β1 expression in irradiated liver. Radiat Res 1990;122:77-85.
26. Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, Schuppan D, et al. Regulation of extracellular matrix synthesis by transforming growth factor-β1 in human fat-storing cells. Gastroenterology 1993;105:245-253.
27. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux AM, et al. Mitogenic effect of transforming growth factor-β1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. HEPATOLOGY 1993;18:137-145.
28. Czaja MF, Winer FR, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989;108:2477-2482.
29. Nagy P, Schaff Z, Lapis K. Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases. HEPATOLOGY 1991; 14:269-273.
30. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factor-β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-1229.
31. Castilla A, Prie to J, Fausto N. Transforming growth factor-β1 and alpha in chronic liver disease - effects of interferon alpha therapy. N Engl J Med 1991;324:933-940.
32. Tefft M, Mitus D, Jaffe N. Irradiation of the liver in children: Acute effects enhanced by concomitant chemotherapeutic administration? Am J Roentgenol Radium Ther Nucl Med 1971;111:165-173.
33. Perry MC. Hepatotoxicity of chemotherapeutic agents. Semin Oncol 1982;9:65-75.
34. Haddad E, Le Bourgeois JP, Kuentz M, Lobo P. Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: Preliminary results. Int J Radiat Oncol Biol Phys 1983;9:1313-1319.
35. Mc Cracken JD, Wheatherall TJ, Oishi N, Janaki L, Boyer C. Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. Cancer Treat Rep 1985; 69:129-131.